Soft tissue sarcoma with lung metastases is an advanced form of cancer in which a malignant tumor that originates in the body's soft tissues has spread to the lungs. Soft tissues include muscles, fat, blood vessels, nerves, tendons, and connective tissues that support and surround other body structures. Soft tissue sarcomas are relatively rare and can develop in almost any part of the body, although they most commonly arise in the arms, legs, or abdomen.
When cancer cells break away from the primary tumor, they can travel through the bloodstream or lymphatic system to distant organs. The lungs are the most common site of metastasis for soft tissue sarcoma because circulating tumor cells often become trapped in the lung's extensive network of blood vessels. Lung metastases may occur months or even years after the initial diagnosis and treatment of the primary sarcoma.
Patients with lung metastases may not always experience symptoms initially. However, as the disease progresses, symptoms can include persistent cough, shortness of breath, chest pain, fatigue, and unintended weight loss. Diagnosis typically involves imaging studies such as chest CT scans, PET scans, and sometimes a biopsy to confirm metastatic disease.
Soft Tissue Sarcoma with Lung Metastases treatment options may include surgery, chemotherapy, targeted therapy, immunotherapy, or radiation therapy, depending on the number, size, and location of the metastatic lesions. Early detection and advances in treatment have improved outcomes for many patients.

Soft Tissue Sarcoma with Lung Metastases Market Infographics

Soft Tissue Sarcoma with Lung Metastases Symptoms, Treatment, epidemiology, companies, drugs, infographic is a short guide to understand the problem and market landscape